Jeffrey A Meckler - Net Worth and Insider Trading
Jeffrey A Meckler Net Worth
The estimated net worth of Jeffrey A Meckler is at least $2 Million dollars as of 2024-11-06. Jeffrey A Meckler is the Director of Travere Therapeutics Inc and owns about 81,000 shares of Travere Therapeutics Inc (TVTX) stock worth over $1 Million. Jeffrey A Meckler is the CEO and Director of Indaptus Therapeutics Inc and owns about 75,374 shares of Indaptus Therapeutics Inc (INDP) stock worth over $86,680. Jeffrey A Meckler is also the CEO of Intec Parent Inc and owns about 2,460 shares of Intec Parent Inc (NTEC) stock worth over $23,690. Details can be seen in Jeffrey A Meckler's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jeffrey A Meckler has not made any transactions after 2024-09-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jeffrey A Meckler
Jeffrey A Meckler Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jeffrey A Meckler owns 6 companies in total, including Intec Parent Inc (NTEC) , Travere Therapeutics Inc (TVTX) , and Novelion Therapeutics Inc (NVLNF) among others .
Click here to see the complete history of Jeffrey A Meckler’s form 4 insider trades.
Insider Ownership Summary of Jeffrey A Meckler
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NTEC | Intec Parent Inc | 2020-07-15 | director & Chief Executive Officer |
| TVTX | Travere Therapeutics Inc | 2024-09-30 | director |
| NVLNF | Novelion Therapeutics Inc | 2016-06-17 | director |
 | | 2014-11-25 | director |
| | 2010-11-17 | other: See Explanation of Responses |
| | 2022-11-21 | director & Chief Executive Officer |
Jeffrey A Meckler Latest Holdings Summary
Jeffrey A Meckler currently owns a total of 3 stocks. Among these stocks, Jeffrey A Meckler owns 81,000 shares of Travere Therapeutics Inc (TVTX) as of September 30, 2024, with a value of $1 Million and a weighting of 92.87%. Jeffrey A Meckler owns 75,374 shares of Indaptus Therapeutics Inc (INDP) as of November 21, 2022, with a value of $86,680 and a weighting of 5.6%. Jeffrey A Meckler also owns 2,460 shares of Intec Parent Inc (NTEC) as of August 28, 2019, with a value of $23,690 and a weighting of 1.53%.
Latest Holdings of Jeffrey A Meckler
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TVTX | Travere Therapeutics Inc | 2024-09-30 | 81,000 | 17.75 | 1,437,750 |
| INDP | Indaptus Therapeutics Inc | 2022-11-21 | 75,374 | 1.15 | 86,680 |
| NTEC | Intec Parent Inc | 2019-08-28 | 2,460 | 9.63 | 23,690 |
Holding Weightings of Jeffrey A Meckler
Jeffrey A Meckler Form 4 Trading Tracker
According to the SEC Form 4 filings, Jeffrey A Meckler has made a total of 1 transactions in Travere Therapeutics Inc (TVTX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Travere Therapeutics Inc is the sale of 40,000 shares on September 30, 2024, which brought Jeffrey A Meckler around $562,400.
According to the SEC Form 4 filings, Jeffrey A Meckler has made a total of 6 transactions in Indaptus Therapeutics Inc (INDP) over the past 5 years, including 6 buys and 0 sells. The most-recent trade in Indaptus Therapeutics Inc is the acquisition of 10,000 shares on November 21, 2022, which cost Jeffrey A Meckler around $18,900.
According to the SEC Form 4 filings, Jeffrey A Meckler has made a total of 0 transactions in Intec Parent Inc (NTEC) over the past 5 years. The most-recent trade in Intec Parent Inc is the acquisition of 250 shares on August 28, 2019, which cost Jeffrey A Meckler around $13,600.
Insider Trading History of Jeffrey A Meckler
- 1
Jeffrey A Meckler Trading Performance
GuruFocus tracks the stock performance after each of Jeffrey A Meckler's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jeffrey A Meckler is -7.63%. GuruFocus also compares Jeffrey A Meckler's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jeffrey A Meckler within 3 months outperforms 2 times out of 10 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jeffrey A Meckler's insider trading performs compared to the benchmark.
Performance of Jeffrey A Meckler
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 11 | | | | | |
| Relative Return to S&P 500(%) | 12.32 | | | | | |
Jeffrey A Meckler Ownership Network
Ownership Network List of Jeffrey A Meckler
Ownership Network Relation of Jeffrey A Meckler
Jeffrey A Meckler Owned Company Details
What does Intec Parent Inc do?
Who are the key executives at Intec Parent Inc?
Jeffrey A Meckler is the director & Chief Executive Officer of Intec Parent Inc. Other key executives at Intec Parent Inc include Chief Business Officer Walt Addison Linscott , Chief Financial Officer Nir Sassi , and Chief Operating Officer Nadav Navon .
Intec Parent Inc (NTEC) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Intec Parent Inc (NTEC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Intec Parent Inc (NTEC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Intec Parent Inc (NTEC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Intec Parent Inc Insider Transactions
Jeffrey A Meckler Mailing Address
Above is the net worth, insider trading, and ownership report for Jeffrey A Meckler. You might contact Jeffrey A Meckler via mailing address: 740 Broadway, 9th Floor, New York Ny 10003.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
